Fibrocystic Breast Disease

1. QXCI Treatment Possibilities

1.1. Breast and hormone specific treatment

Sarcode Stimulation

Click Programs (from menu bar on top of main test screen)

Click Spinal and Sarcodes (from drop down menu)
Click Timed Therapies (from middle of page)
Select treatment time by moving bar
Optionally select or unselect any additional treatment
Click Female Hormone (from second column)
To close click on OK in Therapy Over window and then
click Close
Click Mamary Breast (from fourth column)
To close click on OK in Therapy Over window and then
click Close

Organ specific biofeedback

Click Programs (from menu bar on top of main test screen)

 Click Biofeedback (from drop down menu)

Click Organ Systems (from menu bar on top of biofeedback screen)
Have patient look at screen and focus mind on area of concern
Click Female/Breast (from drop down menu)
To stop click STOP PROGRAM (from upper right corner)

Additional specific biofeedback

Click Programs (from menu bar on top of main test screen)

Click Biofeedback (from drop down menu)
Click Additional (from menu bar on top of biofeedback screen)
Have patient look at screen and focus mind on area of concern
Click Female (from drop down menu)
To stop click STOP PROGRAM (from upper right corner)

1.2. Lymphatic system related treatment

Systemic Treatment

Click Programs (from menu bar on top of main test screen)

Click Spinal and Sarcodes (from drop down menu)
Show Sarcode System
Click Lymph (middle left of page)

 Add an Additional therapy superimposed (by selecting or unselecting above and on left side)
Click Start Treatment

Sarcode Stimulation

Click Programs (from menu bar on top of main test screen)

Click Spinal and Sarcodes (from drop down menu)
Click Timed Therapies (from middle of page)
Select treatment time by moving bar
Optionally select or unselect any additional treatment
Click Congested Lymph Stim (from first column)
To close click on OK in Therapy Over window and then
click Close

2. General Information
Fibrocystic Breast Disease
Single or multiple cysts in the breast.

Causes and Incidence The cause is unclear but is thought to be related to a hormonal imbalance,
with an excess estrogen production and a progesterone deficiency during the luteal phase of the menstrual
cycle. Fibrocystic disease is the most common breast condition, occurs primarily during the childbearing
years, and is estimated to be present in at least half of all women. It accounts for half of all breast surgery.
Disease Process The precise process of cyst formation is unknown. However, a wide variety of
morphologic changes occur in fibrocystic disease, including fibrosis, cyst formation, sclerosing adenosis,
and ductal hyperplasia. The cysts may be nonproliferative, proliferative without atypia, or atypically
hyperplastic.

Symptoms Symptoms typically appear about 1 week before the onset of menstruation and subside
about a week after menstruation stops. They include lumpy breast tissue; tender, burning, aching, heavy
breasts; and nipple discharge.

Diagnostic Tests Clinical evaluation with mammography or ultrasound. The definitive diagnosis is
made by biopsy and histologic examination of tissue.
Treatments

Surgery

Subcutaneous mastectomy for chronic disease

Drugs

Progestin/estrogen injections in second half of cycle to correct hormonal imbalance

General

Support bra, heat compresses to reduce breast pain; forgoing foods with methylxanthines (e.g.,
coffee, tea, chocolate), which increase metabolic breast activity